NCT02525536 A Phase 1 Study Evaluating the Safety, Tolerability and Pharmacokinetics of Trebananib (AMG 386 ) in Adult Japanese Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT02517866 Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in Asia Status COMPLETED Phase PHASE4
NCT02512068 A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Disease Status COMPLETED Phase PHASE3
NCT02497469 An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT02497235 A Phase 1 Positron Emission Tomography Study to Measure Cholesterol 24S-Hydroxylase Target Occupancy of TAK-935 Status COMPLETED Phase PHASE1
NCT02480764 Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With Hypertension Status COMPLETED Phase PHASE3
NCT02480439 A Study to Assess the Relative Bioavailability and to Assess the Effect of Food on the Bioavailability of a TAK-648 Tablet in Healthy Participants Status COMPLETED Phase PHASE1
NCT02477020 A Phase 2 Efficacy and Safety Study of TAK-063 in Participants With an Acute Exacerbation of Schizophrenia Status COMPLETED Phase PHASE2
NCT02475278 Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine Status COMPLETED Phase PHASE2
NCT02467270 Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses Status COMPLETED Phase PHASE2
NCT02461160 Phase 1, TAK-915-1001, Single-Rising Dose, Multiple-Rising Dose, Drug-Drug Interaction, Relative Bioavailability, Food Effect, and Effect on Elderly Participants Study Status COMPLETED Phase PHASE1
NCT02457247 Calcichew D3 Preference Study in Participants Eligible for Calcium and Vitamin D Supplementation. Status COMPLETED Phase PHASE4
NCT02454426 Vortioxetine in Patients With Major Depressive Disorder and Coronary Artery Disease Status WITHDRAWN Phase EARLY_PHASE1
NCT02451150 A Phase 3 Pharmacokinetic Study of TAK-536 (Azilsartan) in Pediatric Patients 6 to Less Than 16 Years With Hypertension Status COMPLETED Phase PHASE3
NCT02443922 Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM Status UNKNOWN Phase NA